About this trial
During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA.
The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.
Eligibility criteria
Qualifiers
Scheduled for THA by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten
Provide signed and dated informed consent
Males or females age > 18 years
Disqualifiers
Neurological problems with sensorial and/or motoric disturbances (Multiple Sclerosis, Parkinson's disease, hemiplegia, …)
Previous surgery of the ipsilateral hip
Ipsilateral neck of femur fracture
Previous contralateral THA
Trial design
Treatments tested in this trial
- Vessel sparing technique
- Vessel ligation technique